Evaluating the cost-effectiveness of clinical and public health measures

John D. Graham, Phaedra S. Corso, Jill M. Morris, Maria Segui-Gomez, Milton C. Weinstein

Research output: Contribution to journalArticle

Abstract

Cost-effectiveness analysis, an analytic tool that expresses as a ratio the cost of obtaining an additional unit of health outcome, can help decision makers achieve more health protection for the same or less cost. We characterize the state of the cost-effectiveness analysis literature by reviewing how this technique is applied to various clinical and public health interventions. We describe the results of cost-effectiveness analyses for over 40 interventions to reduce cancer, heart disease, trauma, and infectious disease. The cost-effectiveness ratios for these interventions vary enormously, from interventions that save money to those that cost more than $1 million per year of life gained. The methods used to derive the cost- effectiveness ratios also vary considerably, and we summarize this variation within each health area. Greater uniformity of analytical practice will be necessary if cost-effectiveness analysis is to become a more influential tool in debates about resource allocation.

Original languageEnglish (US)
Pages (from-to)125-152
Number of pages28
JournalAnnual Review of Public Health
Volume19
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Cost-Benefit Analysis
Public Health
Costs and Cost Analysis
Health
Resource Allocation
Communicable Diseases
Heart Diseases
Wounds and Injuries
Neoplasms

Keywords

  • Cancer
  • Cost-effectiveness
  • Heart disease
  • Infectious disease
  • Trauma

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Graham, J. D., Corso, P. S., Morris, J. M., Segui-Gomez, M., & Weinstein, M. C. (1998). Evaluating the cost-effectiveness of clinical and public health measures. Annual Review of Public Health, 19, 125-152. https://doi.org/10.1146/annurev.publhealth.19.1.125

Evaluating the cost-effectiveness of clinical and public health measures. / Graham, John D.; Corso, Phaedra S.; Morris, Jill M.; Segui-Gomez, Maria; Weinstein, Milton C.

In: Annual Review of Public Health, Vol. 19, 1998, p. 125-152.

Research output: Contribution to journalArticle

Graham, John D. ; Corso, Phaedra S. ; Morris, Jill M. ; Segui-Gomez, Maria ; Weinstein, Milton C. / Evaluating the cost-effectiveness of clinical and public health measures. In: Annual Review of Public Health. 1998 ; Vol. 19. pp. 125-152.
@article{07cf0070af6e4bc486fbe30ed725eafe,
title = "Evaluating the cost-effectiveness of clinical and public health measures",
abstract = "Cost-effectiveness analysis, an analytic tool that expresses as a ratio the cost of obtaining an additional unit of health outcome, can help decision makers achieve more health protection for the same or less cost. We characterize the state of the cost-effectiveness analysis literature by reviewing how this technique is applied to various clinical and public health interventions. We describe the results of cost-effectiveness analyses for over 40 interventions to reduce cancer, heart disease, trauma, and infectious disease. The cost-effectiveness ratios for these interventions vary enormously, from interventions that save money to those that cost more than $1 million per year of life gained. The methods used to derive the cost- effectiveness ratios also vary considerably, and we summarize this variation within each health area. Greater uniformity of analytical practice will be necessary if cost-effectiveness analysis is to become a more influential tool in debates about resource allocation.",
keywords = "Cancer, Cost-effectiveness, Heart disease, Infectious disease, Trauma",
author = "Graham, {John D.} and Corso, {Phaedra S.} and Morris, {Jill M.} and Maria Segui-Gomez and Weinstein, {Milton C.}",
year = "1998",
doi = "10.1146/annurev.publhealth.19.1.125",
language = "English (US)",
volume = "19",
pages = "125--152",
journal = "Annual Review of Public Health",
issn = "0163-7525",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Evaluating the cost-effectiveness of clinical and public health measures

AU - Graham, John D.

AU - Corso, Phaedra S.

AU - Morris, Jill M.

AU - Segui-Gomez, Maria

AU - Weinstein, Milton C.

PY - 1998

Y1 - 1998

N2 - Cost-effectiveness analysis, an analytic tool that expresses as a ratio the cost of obtaining an additional unit of health outcome, can help decision makers achieve more health protection for the same or less cost. We characterize the state of the cost-effectiveness analysis literature by reviewing how this technique is applied to various clinical and public health interventions. We describe the results of cost-effectiveness analyses for over 40 interventions to reduce cancer, heart disease, trauma, and infectious disease. The cost-effectiveness ratios for these interventions vary enormously, from interventions that save money to those that cost more than $1 million per year of life gained. The methods used to derive the cost- effectiveness ratios also vary considerably, and we summarize this variation within each health area. Greater uniformity of analytical practice will be necessary if cost-effectiveness analysis is to become a more influential tool in debates about resource allocation.

AB - Cost-effectiveness analysis, an analytic tool that expresses as a ratio the cost of obtaining an additional unit of health outcome, can help decision makers achieve more health protection for the same or less cost. We characterize the state of the cost-effectiveness analysis literature by reviewing how this technique is applied to various clinical and public health interventions. We describe the results of cost-effectiveness analyses for over 40 interventions to reduce cancer, heart disease, trauma, and infectious disease. The cost-effectiveness ratios for these interventions vary enormously, from interventions that save money to those that cost more than $1 million per year of life gained. The methods used to derive the cost- effectiveness ratios also vary considerably, and we summarize this variation within each health area. Greater uniformity of analytical practice will be necessary if cost-effectiveness analysis is to become a more influential tool in debates about resource allocation.

KW - Cancer

KW - Cost-effectiveness

KW - Heart disease

KW - Infectious disease

KW - Trauma

UR - http://www.scopus.com/inward/record.url?scp=0031866909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031866909&partnerID=8YFLogxK

U2 - 10.1146/annurev.publhealth.19.1.125

DO - 10.1146/annurev.publhealth.19.1.125

M3 - Article

C2 - 9611615

AN - SCOPUS:0031866909

VL - 19

SP - 125

EP - 152

JO - Annual Review of Public Health

JF - Annual Review of Public Health

SN - 0163-7525

ER -